Answers are grounded in this paper and cite their sources.
Pompe disease is a rare, autosomal recessive disease caused by the defi ciency of lysosomal acid α-glucosidase (GAA), an enzyme that degrades glycogen.The accumulated glycogen in tissues, especially cardiac, respiratory-specifi c, and major skeletal muscle groups, disrupts the cellular architecture and function leading to multisystem pathology and early mortality.The Exploratory Muscle Biopsy Assessment Study (EMBASSY; NCT01288027), sponsored by Genzyme, a sanofi company, was conducted to evaluate glycogen clearance in muscle tissue samples collected pre-and post-alglucosidase alfa treatment in patients with adult Pompe disease.Sixteen patients (44% male) were enrolled in this open-label, single
No takes yet. Share an insight, caveat, or question.
Thurberg et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: